Guidelines

P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates

January 2016
P2.05 Intravenous immunoglobulins as a preventive treatment of maternofoetal platelet alloimmunisation

January 2016
P2.06 Salt but not glucocorticosteroïds enhances Th17 differentiation from naïve T cells in vitro

January 2016
P2.07 Characterization of a novel innate CD8+ T cell lineage generated in human thymus

January 2016
P2.08 EBV associated hemophagocytic lymphohistiocytosis: a common infection running a life-threatening course

January 2016
P2.09 Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report

January 2016
P2.10 Role of Extracellular Vesicles for Thrombosis in Paroxysmal Nocturnal Hemoglobinuria patients

January 2016
P3.01 NGS based HLA-genotyping using 2 reagent kits (Omixon, GenDx) and 3 software applications: NGSengine, Twin and SeqNext-HLA

January 2016
P3.02 Ponatinib as bridge to haematopoietic stem cell transplantation in a patient with a myeloid/lymphoid neoplasm with eosinophilia and abnormality of FGFR1: a case report

January 2016
P3.03 Anemia, thrombocytopenia and radiculitis in the setting of allogeneic stem cell transplantation

January 2016

Top